Rhumbline Advisers Quidel Ortho Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Quidel Ortho Corp stock. As of the latest transaction made, Rhumbline Advisers holds 116,229 shares of QDEL stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,229

Previous 137,376 15.39%

Holding current value

$4.85 Million

Previous $4.56 Million 16.11%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$29.96 - $46.4 $633,564 - $981,220	-21,147 Reduced 15.39%	116,229 $5.3 Million
Q2 2024 Aug 01, 2024	SELL	$32.9 - $47.0 $183,911 - $262,730	-5,590 Reduced 3.91%	137,376 $4.56 Million
Q1 2024 May 09, 2024	SELL	$41.76 - $74.73 $428,123 - $766,131	-10,252 Reduced 6.69%	142,966 $6.85 Million
Q4 2023 Feb 08, 2024	BUY	$58.16 - $75.44 $47,458 - $61,559	816 Added 0.54%	153,218 $11.3 Million
Q3 2023 Nov 09, 2023	SELL	$70.9 - $88.63 $608,605 - $760,799	-8,584 Reduced 5.33%	152,402 $11.1 Million
Q2 2023 Aug 08, 2023	BUY	$81.09 - $94.16 $539,491 - $626,446	6,653 Added 4.31%	160,986 $13.3 Million
Q1 2023 May 11, 2023	SELL	$82.98 - $91.46 $181,394 - $199,931	-2,186 Reduced 1.4%	154,333 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$66.93 - $97.5 $458,068 - $667,290	6,844 Added 4.57%	156,519 $13.4 Million
Q3 2022 Nov 10, 2022	BUY	$69.86 - $107.63 $812,890 - $1.25 Million	11,636 Added 8.43%	149,675 $10.7 Million
Q2 2022 Aug 11, 2022	BUY	$89.06 - $117.64 $12.3 Million - $16.2 Million	138,039 New	138,039 $13.4 Million

Others Institutions Holding QDEL

# of Institutions

287

Shares Held

67.3M

Call Options Held

337K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.79B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Quidel Ortho Corp Transaction History